Skip to main content

Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q4 '22

By: Newsfile

Dallas, Texas--(Newsfile Corp. - April 10, 2023) - Bio-Path Holdings, Inc. (NASDAQ: BPTH): The full report can be accessed by clicking on the following link: https://stonegateinc.com/reports/BPTH_Q422.pdf

To view the full announcement, including downloadable images, bios, and more, click here.

Key Takeaways:

  • Owning the Breakthrough Technology
  • Ongoing Clinical Trials
  • First Patients Recently Dosed

Cannot view this image? Visit: https://images.newsfilecorp.com/files/7294/161882_figure1_550.jpg

Click image above to view full announcement.


About Stonegate Capital Partners
Stonegate Capital Partners is a Dallas-based corporate advisory firm dedicated to serving the specialized needs of small-cap public companies. Since our inception, our mission has been to find innovative, undervalued public companies for our network of leading institutional investors who seek high-quality investment opportunities.

Contacts:

Stonegate Capital Partners
(214) 987-4121
info@stonegateinc.com

Source: Stonegate, Inc.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/161882

Recent Quotes

View More
Symbol Price Change (%)
AMZN  204.89
+3.74 (1.86%)
AAPL  264.08
+0.20 (0.08%)
AMD  198.97
-4.11 (-2.02%)
BAC  53.21
+0.47 (0.89%)
GOOG  303.08
+0.26 (0.09%)
META  642.01
+2.72 (0.43%)
MSFT  400.05
+3.19 (0.80%)
NVDA  187.50
+2.53 (1.37%)
ORCL  155.83
+1.86 (1.21%)
TSLA  411.15
+0.52 (0.13%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.